Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsDec 5, 2024 11:31 ET

Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsDec 5, 2024 11:31 ET

Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)

TipRanksDec 5, 2024 11:18 ET

Heron Therapeutics Price Target Maintained With a $4.00/Share by Needham

Dow JonesDec 4, 2024 06:56 ET

Heron Therapeutics Analyst Ratings

BenzingaDec 4, 2024 06:46 ET

Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 13, 2024 09:31 ET

Heron Therapeutics (HRTX) Gets a Buy From Northland Securities

TipRanksNov 13, 2024 08:57 ET

Heron Therapeutics Analyst Ratings

BenzingaNov 13, 2024 04:43 ET

Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Cuts Target Price to $4

Moomoo NewsNov 12, 2024 15:32 ET

Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsSep 26, 2024 09:31 ET

Heron Therapeutics Analyst Ratings

BenzingaSep 25, 2024 13:42 ET

Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsSep 25, 2024 12:32 ET

Heron Therapeutics Analyst Ratings

BenzingaAug 7, 2024 06:22 ET

Heron Therapeutics Analyst Ratings

BenzingaJun 13, 2024 13:38 ET

Heron Therapeutics Analyst Ratings

BenzingaMay 16, 2024 05:31 ET

Analysts Are Bullish on These Healthcare Stocks: AN2 Therapeutics, Inc. (ANTX), Heron Therapeutics (HRTX)

TipRanksMay 15, 2024 16:45 ET

Heron Therapeutics Analyst Ratings

BenzingaMay 8, 2024 05:37 ET

Heron Therapeutics Analyst Ratings

BenzingaApr 23, 2024 07:12 ET

Heron Therapeutics Analyst Ratings

BenzingaApr 11, 2024 06:02 ET

Needham Reiterates Buy on Heron Therapeutics, Maintains $5 Price Target

BenzingaApr 11, 2024 06:02 ET